Skip to main content
LGND
NASDAQ Life Sciences

Ligand Q3 Adjusted EPS Beats at $2.67 as Revenue Jumps 71.5% to $149M

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$316.21
Mkt Cap
$6.304B
52W Low
$175.89
52W High
$326.63
52W Position info
80% above low
Off High info
3.2% below high
Rel. Volume info
1.0× avg
Market data snapshot near publication time

LGND sits 80% above its 52-week low of $175.89.

Summary

Ligand's Q3 adjusted EPS came in at $2.67 versus the $2.38 consensus, and revenue of $149.03 million blew past the $77.23 million analysts expected, up 71.5% year-over-year. The GAAP picture is a $28.49 million loss, or $1.43 per share, a swing from Q2's profit, but that reflects the accounting on the XOMA Royalty acquisition closed in July rather than operating weakness. Royalty revenue rose 51% to $70.3 million, and the company raised 2026 adjusted EPS guidance to $9, per the 8-K filed this morning. The stock sits near its 52-week high of $326.63 after gaining 68.6% this year, so the bar was high and the revenue beat clears it. Watch whether the raised guidance holds through Q4 as Filspari and the newly acquired royalty streams ramp.

At the time of this announcement, LGND was trading at $316.21 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.3B. The 52-week trading range was $175.89 to $326.63. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

LGND - Latest Insights

LGND
Oct 30, 2026, 4:47 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $324.00
Real-time Price: $300.01 info
Change: -$23.99 (-7%) info
Market Cap: $6.035B info
LGND
Oct 29, 2026, 7:14 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $311.87
Real-time Price: $300.01 info
Change: -$11.86 (-4%) info
Market Cap: $6.035B info
LGND
Oct 29, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $311.87
Real-time Price: $300.01 info
Change: -$11.86 (-4%) info
Market Cap: $6.035B info
LGND
Sep 24, 2026, 7:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $298.41
Real-time Price: $300.01 info
Change: +$1.60 (+0.54%) info
Market Cap: $6.035B info
LGND
Sep 22, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $290.00
Real-time Price: $300.01 info
Change: +$10.01 (+3%) info
Market Cap: $6.035B info